The perimenopausal period can last more than a decade and is attended by significant morbidity including irregular reproductive cycles, dysfunctional uterine bleeding, urogenital changes, impaired fertility, declining bone mass, vasomotor symptoms, and psychological impairment. The first sign of ovarian aging is a rise in circulating FSH concentrations. We have identified that young women have high levels of hypo-glycosylated FSH21 while older women have high levels of fully-glycosylated FSH24. The biological activity of hypo- glycosylated FSH21 is much greater on the ovary where it binds efficiently to its receptor and stimulates estrogen production and follicle development. In contrast, the fully-glycosylated FSH24 has lesser effects at the level of the ovary, but has stimulatory effect on bone remodeling cells that promote osteoporosis. Thus, the changes in FSH glycosylation associated with aging and their actions in both traditional (ovarian granulosa cells) and non- traditional FSH target tissues (bone) requires immediate attention. The central hypothesis for this project is that in the face of a senescing ovary, the additional switch of hypo- to fully-glycosylated FSH further compromises reproductive potential and at the same time may hasten bone loss. The proposed Specific Aims will identify how and why the age dependent differences in FSH glycosylation alter the function of ovarian follicles and bone, a nontraditional FSH target. We will identify the specific intracellular signals that distinguish the action of hypo- glycosylated hFSH21 from the age-related fully-glycosylated FSH24 isoform. Mechanistic studies will demonstrate how these signals contribute to enhanced or reduced bioactivity in the ovary and bone. This project is innovative because it studies for the first time the impact of naturally occurring FSH glycoforms on the function of aging ovaries and on osteoclast formation in a nontraditional FSH target, bone. We are in an exclusive position to establish the mechanism of action of these novel FSH glycoforms using in vivo and in vitro models and multiple FSH target tissues. The impact of this work is that once we identify the unique biologic activities and functions of FSH glycoforms, we can then use this knowledge to develop strategies to maintain ovarian function and limit bone turnover. We have an outstanding team working in an outstanding environment, and have the tools necessary to complete this exciting and important project. Understanding how the age-dependent change in FSH glycoforms directs activities in multiple target tissue (ovary and bone) offers a unique opportunity to develop novel approaches to improve fertility and reduce age associated morbidity. This proposal has translational relevance that could be important for enhanced success for assisted reproductive technologies and the health of pre- and post-menopausal women.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG029531-07
Application #
9554754
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
7
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Wichita State University
Department
Type
DUNS #
053078127
City
Wichita
State
KS
Country
United States
Zip Code
67260
Roy, Sambit; Gandra, Divya; Seger, Christina et al. (2018) Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells. Endocrinology 159:3433-3445
Kumar, T Rajendra (2018) Fshb Knockout Mouse Model, Two Decades Later and Into the Future. Endocrinology 159:1941-1949
Das, Nandana; Kumar, T Rajendra (2018) Molecular regulation of follicle-stimulating hormone synthesis, secretion and action. J Mol Endocrinol 60:R131-R155
Gilbert, Sara Babcock; Roof, Allyson K; Rajendra Kumar, T (2018) Mouse models for the analysis of gonadotropin secretion and action. Best Pract Res Clin Endocrinol Metab 32:219-239
Kumar, T Rajendra (2018) Extragonadal Actions of FSH: A Critical Need for Novel Genetic Models. Endocrinology 159:2-8
Kumar, T Rajendra (2017) The SO(H)L(H) ""O"" drivers of oocyte growth and survival but not meiosis I. J Clin Invest 127:2044-2047
Romereim, Sarah M; Summers, Adam F; Pohlmeier, William E et al. (2017) Gene expression profiling of bovine ovarian follicular and luteal cells provides insight into cellular identities and functions. Mol Cell Endocrinol 439:379-394
Liu, Peng; Ji, Yaoting; Yuen, Tony et al. (2017) Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature 546:107-112
Wang, Huizhen; Hastings, Richard; Miller, William L et al. (2016) Fshb-iCre mice are efficient and specific Cre deleters for the gonadotrope lineage. Mol Cell Endocrinol 419:124-38
Wang, Huizhen; May, Jacob; Butnev, Viktor et al. (2016) Evaluation of in vivo bioactivities of recombinant hypo- (FSH21/18) and fully- (FSH24) glycosylated human FSH glycoforms in Fshb null mice. Mol Cell Endocrinol 437:224-236

Showing the most recent 10 out of 40 publications